WASHINGTON, Oct. 2, 2025 /PRNewswire/ -- Genesys Impact is proud to announce that it has officially achieved two ISO certifications: ISO 27001 for Information Security Management, and ISO 9001 for ...

AUCKLAND, New Zealand--(BUSINESS WIRE)-- Informatica (NYSE: INFA), a leader in enterprise AI-powered cloud data management, today announced that it has been chosen by leading New Zealand utility ...

Extends Genesys Cloud footprint with full-service cloud regions in Singapore and Mexico, with plans for the EU Sovereign Cloud and Saudi Arabia to expand secure, compliant access worldwide Achieves ...

DENVER--(BUSINESS WIRE)--Today at Xperience 2024 — the customer experience (CX) event of the year — Genesys® unveiled multiple innovations to accelerate the impact of AI, empowering organizations to ...

Genesys announced a $1.5 billion investment from Salesforce and ServiceNow on July 31, with each company contributing an equal amount. The investment reinforces Genesys' position as a strategic ...

The deal is expected to close in the first quarter of fiscal year 2025 Radarr is run by co-founders Ram Bhamidi and Prerna Pant, and was set up in 2013 Based in San Francisco, H&F was founded in 1984 ...

The weight of a digital transformation looms over on-premises legacy infrastructure and vendors because, as Sid Nag, research VP at Gartner put it, “At this point, cloud adoption is mainstream.” The ...

Nov. 12, 2019 — To accelerate digital transformation, organizations in every industry are modernizing their on-premises technologies by adopting cloud-native applications. According to the ...

Vancouver, British Columbia--(Newsfile Corp. - September 25, 2025) - Data Watts Partners Inc. (CSE: DWTZ) ("Data Watts" or the "Company"), a technology-focused investment firm at the forefront of the ...

Customers have many interactions with your business — but not all of them are with a human. Every interaction adds to the customer experience, either positively or negatively. Sometimes your customer ...

BANGALORE, April 3 (Reuters) - Cell Genesys Inc. on Tuesday said a second mid-stage trial of its treatment for prostate cancer showed better-than-expected median survival. Shares of the biotechnology ...